{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T08:31:29Z","timestamp":1779352289836,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003921","name":"Department of Health and Aged Care, Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.vaccine.2023.11.047","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T18:40:40Z","timestamp":1701801640000},"page":"53-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The relative effectiveness of three and four doses of COVID-19 vaccine in Victoria, Australia: A data linkage study"],"prefix":"10.1016","volume":"42","author":[{"given":"Jose T.","family":"Canevari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen C.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Logan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey L.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis E.","family":"Wollersheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9656-557X","authenticated-orcid":false,"given":"Suman S.","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheena G.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.vaccine.2023.11.047_b0005","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1056\/NEJMc2025179","article-title":"Rapid decay of anti-SARS-CoV-2 antibodies in persons with mild Covid-19","volume":"383","author":"Ibarrondo","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2023.11.047_b0010","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1038\/s41467-022-29225-4","article-title":"Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors","volume":"13","author":"Perez-Alos","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2023.11.047_b0015","series-title":"Statement on the update of WHO\u2019s working definitions and tracking system for SARS-CoV-2 variants of concern and variants of interest","author":"World Health Organization","year":"2023"},{"issue":"12","key":"10.1016\/j.vaccine.2023.11.047_b0020","doi-asserted-by":"crossref","first-page":"e1010022","DOI":"10.1371\/journal.ppat.1010022","article-title":"Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination","volume":"17","author":"Davis","year":"2021","journal-title":"PLoS Pathog"},{"issue":"7871","key":"10.1016\/j.vaccine.2023.11.047_b0025","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41586-021-03777-9","article-title":"Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization","volume":"596","author":"Planas","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2023.11.047_b0030","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMoa2108891","article-title":"Effectiveness of COVID-19 vaccines against the B.1.617.2 variant","volume":"385","author":"Bernal","year":"2021","journal-title":"New Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2023.11.047_b0035","doi-asserted-by":"crossref","first-page":"e460","DOI":"10.1093\/cid\/ciac381","article-title":"Protection of messenger RNA vaccines against hospitalized coronavirus disease 2019 in adults over the first year following authorization in the United States","volume":"76","author":"Tenforde","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2023.11.047_b0040","article-title":"Prior infections and effectiveness of SARS-CoV-2 vaccine in test-negative study: a systematic review and meta-analysis","author":"Tsang","year":"2022","journal-title":"medRxiv"},{"issue":"6","key":"10.1016\/j.vaccine.2023.11.047_b0045","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJMp2215780","article-title":"Bivalent Covid-19 vaccines \u2013 a cautionary tale","volume":"388","author":"Offit","year":"2023","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.vaccine.2023.11.047_b0050","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa2114255","article-title":"Protection of BNT162b2 vaccine booster against Covid-19 in Israel","volume":"385","author":"Bar-On","year":"2021","journal-title":"N Engl J Med"},{"issue":"43","key":"10.1016\/j.vaccine.2023.11.047_b0055","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1016\/j.vaccine.2022.09.029","article-title":"Relative effectiveness of COVID-19 vaccination with 3 compared to 2 doses against SARS-CoV-2 B.1.1.529 (Omicron) among an Australian population with low prior rates of SARS-CoV-2 infection","volume":"40","author":"Liu","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.11.047_b0060","unstructured":"UK Health Security Agency. COVID-19 vaccine surveillance report - Week 24; 2022 [Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/1083443\/Vaccine-surveillance-report-week-24.pdf]."},{"key":"10.1016\/j.vaccine.2023.11.047_b0065","unstructured":"Australian Bureau of Statistics (ABS). Greater Melbourne 2021 Census All persons QuickStats Canberra: ABS; 2022 [updated 2022; cited 2022 18 October]. Available from: https:\/\/www.abs.gov.au\/census\/find-census-data\/quickstats\/2021\/2GMEL."},{"issue":"1","key":"10.1016\/j.vaccine.2023.11.047_b0070","doi-asserted-by":"crossref","first-page":"e044640","DOI":"10.1136\/bmjopen-2020-044640","article-title":"Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies","volume":"11","author":"Pijls","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2023.11.047_b0075","unstructured":"Australian Government. Australian Immunisation Register Canberra: Australian Government; 2023 [Available from: https:\/\/www.servicesaustralia.gov.au\/australian-immunisation-register]."},{"key":"10.1016\/j.vaccine.2023.11.047_b0080","first-page":"44","article-title":"An evaluation of enhanced surveillance of hospitalised COVID-19 patients to inform the public health response in Victoria","volume":"2020","author":"Curtis","year":"2018","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.vaccine.2023.11.047_b0085","unstructured":"Victorian Department of Health. Datasets available in the Centre for Victorian Data Linkage\u2019s Integrated Data Resource Melbourne: Government of Victoria; 2023 [Available from: https:\/\/www.health.vic.gov.au\/sites\/default\/files\/migrated\/files\/collections\/factsheets\/c\/cvdl-datasets-available-in-integrated-data-resource.docx]."},{"key":"10.1016\/j.vaccine.2023.11.047_b0090","unstructured":"Australian Bureau of Statistics. Statistical Area Level 1 Canberra: Australian Bureau of Statistics; 2021 [Available from: https:\/\/www.abs.gov.au\/statistics\/standards\/australian-statistical-geography-standard-asgs-edition-3\/jul2021-jun2026\/main-structure-and-greater-capital-city-statistical-areas\/statistical-area-level-1]."},{"key":"10.1016\/j.vaccine.2023.11.047_b0095","unstructured":"Australian Bureau of Statistics. Socio-Economic Advantage and Disadvantage. In: Australian Bureau of Statistics, editor. Canberra: Government of Australia; 2018."},{"key":"10.1016\/j.vaccine.2023.11.047_b0100","unstructured":"ABC News. Fourth COVID-19 vaccine shots are available, but only for certain groups of people. Here's who is eligible: Australian Broadcasting Corporation; 2022 [Available from: https:\/\/www.abc.net.au\/news\/2022-04-04\/covid-19-vaccine-fourth-dose-booster-shot-australian-eligible\/100963788]."},{"key":"10.1016\/j.vaccine.2023.11.047_b0105","unstructured":"Australian Government Department of Health. Expanded ATAGI recommendations on winter COVID-19 booster doses for people at increased risk of severe COVID-19 2022 [updated 25 May 2022 Available from: https:\/\/www.health.gov.au\/news\/expanded-atagi-recommendations-on-winter-covid-19-booster-doses-for-people-at-increased-risk-of-severe-covid-19]."},{"key":"10.1016\/j.vaccine.2023.11.047_b0110","unstructured":"Australian Government Department of Health and Aged Care. Expanded eligibility for fourth COVID-19 vaccine dose 2022 [updated 7 July 2022 Available from: https:\/\/www.health.gov.au\/ministers\/the-hon-mark-butler-mp\/media\/expanded-eligibility-for-fourth-covid-19-vaccine-dose]."},{"key":"10.1016\/j.vaccine.2023.11.047_b0115","unstructured":"Operation COVID Shield. COVID-19 Vaccine Roll-out update - 22 December 2022 Canberra: Government of Australia; 2022 [updated 22 Dec 2022. Available from: https:\/\/www.health.gov.au\/sites\/default\/files\/2022-12\/covid-19-vaccine-rollout-update-22-december-2022.pdf]."},{"key":"10.1016\/j.vaccine.2023.11.047_b0120","unstructured":"Australian Government. ATAGI 2023 booster advice Canberra: Australian Government; 2023 [updated 8 Feb 2023. Available from: https:\/\/www.health.gov.au\/news\/atagi-2023-booster-advice]."},{"key":"10.1016\/j.vaccine.2023.11.047_b0125","unstructured":"Team RC. R: A language and environment for statistical computing. R Foundation for Statistical Computing. Vienna, Austria. URL: https:\/\/www.R-project.org\/.4.2.3ed2022."},{"key":"10.1016\/j.vaccine.2023.11.047_b0130","unstructured":"Government of Victoria. Public Health and Wellbeing Act 2008 (Act Number 46\/2008). Authorised version incorporating amendments as at 30 Aug 2022 Melbourne: Government of Victoria; 2023 [Available from: https:\/\/www.legislation.vic.gov.au\/in-force\/acts\/public-health-and-wellbeing-act-2008\/061."},{"key":"10.1016\/j.vaccine.2023.11.047_b0135","unstructured":"Government of Victoria. Health Records Act 2001 Melbourne: Department of Health; 2023 [Available from: https:\/\/www.health.vic.gov.au\/legislation\/health-records-act]."},{"issue":"9","key":"10.1016\/j.vaccine.2023.11.047_b0140","doi-asserted-by":"crossref","first-page":"2200121","DOI":"10.2807\/1560-7917.ES.2022.27.9.2200121","article-title":"Risk of severe COVID-19 from the Delta and Omicron variants in relation to vaccination status, sex, age and comorbidities - surveillance results from southern Sweden, July 2021 to January 2022","volume":"27","author":"Kahn","year":"2022","journal-title":"Euro Surveill"},{"issue":"9","key":"10.1016\/j.vaccine.2023.11.047_b0145","first-page":"e2232760","article-title":"Estimated effectiveness of COVID-19 vaccines against omicron or delta symptomatic infection and severe outcomes","volume":"5","author":"Buchan","year":"2022","journal-title":"JAMANetw Open"},{"issue":"10332","key":"10.1016\/j.vaccine.2023.11.047_b0150","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(22)00462-7","article-title":"Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study","volume":"399","author":"Nyberg","year":"2022","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2023.11.047_b0155","doi-asserted-by":"crossref","first-page":"139","DOI":"10.15585\/mmwr.mm7104e3","volume":"71","author":"Thompson","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.vaccine.2023.11.047_b0160","first-page":"2050","article-title":"Reflections on modern methods: linkage error bias","volume":"48","author":"Doidge","year":"2019","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.vaccine.2023.11.047_b0165","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/aje\/kwj155","article-title":"Accounting for independent nondifferential misclassification does not increase certainty that an observed association is in the correct direction","volume":"164","author":"Greenland","year":"2006","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.vaccine.2023.11.047_b0170","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00001648-199205000-00005","article-title":"Bias from nondifferential but dependent misclassification of exposure and outcome","volume":"3","author":"Kristensen","year":"1992","journal-title":"Epidemiology"},{"issue":"6549","key":"10.1016\/j.vaccine.2023.11.047_b0175","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1126\/science.abh1282","article-title":"Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose","volume":"372","author":"Reynolds","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2023.11.047_b0180","doi-asserted-by":"crossref","first-page":"e074404","DOI":"10.1136\/bmj-2022-074404","article-title":"The imprinting effect of covid-19 vaccines: an expected selection bias in observational studies","volume":"381","author":"Monge","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2023.11.047_b0185","unstructured":"Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes Changes to Simplify Use of Bivalent mRNA COVID-19 Vaccines Washington DC: Government of the United States of America; 2023 [Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-authorizes-changes-simplify-use-bivalent-mrna-covid-19-vaccines]."},{"key":"10.1016\/j.vaccine.2023.11.047_b0190","unstructured":"Ministry of Health. Vaccines Tel Aviv: Government of Israel; 2023 [Available from: https:\/\/corona.health.gov.il\/en\/vaccine-for-covid\/]."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23013932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23013932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:32:49Z","timestamp":1759404769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23013932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0264410X23013932"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.11.047","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relative effectiveness of three and four doses of COVID-19 vaccine in Victoria, Australia: A data linkage study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.11.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}